Arkolith/Insider Trading/ABCL/Form 4

Booth Andrew

Chief Financial OfficerAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed Dec 10, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2021Option exercise(M)500K$0.32$160K554K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2021Option exercise(M)500K—$05.4M

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-069084) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML